Scaling Your Biotech Organisation: Key Milestones
As a leader of a biotech firm, you’ll know that scaling your teams is an ever-present challenge, as need to balance team growth, while [...]
FDA rejects Disc's rare disease drug despite commissioner's voucher Read more
'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments Read more
After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio Read more
As a leader of a biotech firm, you’ll know that scaling your teams is an ever-present challenge, as need to balance team growth, while [...]
The hiring landscape in biotech has been incredibly volatile over recent years, as investor expectations have changed, new technologies have disrupted the industry and [...]